This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Oxford United returned to winning ways on Friday at home when they defeated Southampton 2-1. It was the hosts’ first win in five matches, following one draw and three defeats. The win helped Oxford ...
Oxford United welcome Southampton to the Kassam Stadium on Boxing Day, with both sides looking to steer their seasons in the right direction. For Oxford, the challenge is clear: halt a slide that has ...
With London hospitalisations for flu tripling in early December compared to the year before, families are now being urged to remember the simple ways to keep their homes virus-free. A new study has ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well ...
The first clinical trial in patients has just been completed and shows that the treatment can restore levels of the protein progranulin to normal in individuals carrying a gene mutation that typically ...
Championship title favourites Oxford begin their title challenge this coming Saturday in an opening day encounter with Portsmouth at Kassam Stadium. Since both Oxford and Portsmouth are looking to ...
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback